What is the difference between Mounjaro and Ozempic?

Mounjaro, a relatively newer entrant in the diabetes medication market, contains the active ingredient mounjagliptin. This compound belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Mounjaro In Dubai works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. By inhibiting DPP-4, mounjagliptin prolongs the action of incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).